Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, launched today an integrated suite of tools for analyzing next-generation sequencing (NGS) cancer genome data. In particular, the Cancer Genome Analysis Suite contains a tool engineered to provide the high sensitivity required for identifying low-frequency point mutations, hard-to-find discrepancies in DNA sequences that are a genetic hallmark of tumor development and evolution.
Help employers find you! Check out all the jobs and post your resume.
ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, launched today an integrated suite of tools for analyzing next-generation sequencing (NGS) cancer genome data. In particular, the Cancer Genome Analysis Suite contains a tool engineered to provide the high sensitivity required for identifying low-frequency point mutations, hard-to-find discrepancies in DNA sequences that are a genetic hallmark of tumor development and evolution.
Help employers find you! Check out all the jobs and post your resume.
